Blake P. Moore

498 total citations
19 papers, 414 citations indexed

About

Blake P. Moore is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Blake P. Moore has authored 19 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Genetics. Recurrent topics in Blake P. Moore's work include Virus-based gene therapy research (7 papers), Respiratory viral infections research (5 papers) and Herpesvirus Infections and Treatments (3 papers). Blake P. Moore is often cited by papers focused on Virus-based gene therapy research (7 papers), Respiratory viral infections research (5 papers) and Herpesvirus Infections and Treatments (3 papers). Blake P. Moore collaborates with scholars based in United States and Canada. Blake P. Moore's co-authors include Gregory K. Friedman, Elizabeth A. Beierle, Danny R. Welch, Rajeev S. Samant, Douglas R. Hurst, Li Nan, G. Yancey Gillespie, James M. Markert, Xiaosi Han and Catherine P. Langford and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Blake P. Moore

19 papers receiving 411 citations

Peers

Countries citing papers authored by Blake P. Moore

Since Specialization

Citations

This map shows the geographic impact of Blake P. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blake P. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blake P. Moore more than expected).

Fields of papers citing papers by Blake P. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blake P. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blake P. Moore. The network helps show where Blake P. Moore may publish in the future.

Co-authorship network of co-authors of Blake P. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Blake P. Moore. A scholar is included among the top collaborators of Blake P. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blake P. Moore. Blake P. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts 2019 ·Translational Oncology ·(unknown), (unknown), (unknown), Jamie M. Aye, (unknown), Raoud Marayati, Jerry E. Stewart, Venkatram R. Atigadda, Elizabeth Mroczek‐Musulman, Blake P. Moore, Elizabeth A. Beierle, Gregory K. Friedman	4
2	FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts 2018 ·Scientific Reports ·(unknown), (unknown), (unknown), Jamie M. Aye, Elizabeth Mroczek‐Musulman, Blake P. Moore, Jerry E. Stewart, Gregory K. Friedman, Elizabeth A. Beierle	23
3	UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts 2018 ·Journal of Neuro-Oncology ·(unknown), (unknown), (unknown), Jamie M. Aye, (unknown), Venkatram R. Atigadda, Blake P. Moore, Li Nan, Jerry E. Stewart, Anita B. Hjelmeland, Gregory K. Friedman, Elizabeth A. Beierle	11
4	Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression 2018 ·Scientific Reports ·Gregory K. Friedman, Joshua D. Bernstock, Dongquan Chen, Li Nan, Blake P. Moore, Virginia Kelly, (unknown), Catherine P. Langford, Xiaosi Han, (unknown), Elizabeth A. Beierle, G. Yancey Gillespie, James M. Markert	59
5	Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002 2017 ·Molecular Therapy — Oncolytics ·(unknown), Rong Li, Blake P. Moore, Li Nan, Virginia Kelly, Xiaosi Han, Elizabeth A. Beierle, James M. Markert, Jianmei W. Leavenworth, G. Yancey Gillespie, Gregory K. Friedman	18
6	PCM-09COMPARISON OF THE SENSITIVITIES OF PEDIATRIC HIGH-GRADE BRAIN TUMOR VERSUS ADULT GLIOBLASTOMA XENOGRAFTS TO ENGINEERED ONCOLYTIC HERPES SIMPLEX VIROTHERAPY 2016 ·Neuro-Oncology ·(unknown), Blake P. Moore, Li Nan, (unknown), James M. Markert, G. Yancey Gillespie, Gregory K. Friedman	3
7	The Evolutionary History of MAPL (Mitochondria-Associated Protein Ligase) and Other Eukaryotic BAM/GIDE Domain Proteins 2015 ·PLoS ONE ·Jeremy G. Wideman, Blake P. Moore	4
8	Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses 2015 ·Neuro-Oncology ·Gregory K. Friedman, Blake P. Moore, Li Nan, Virginia Kelly, (unknown), Catherine P. Langford, Hui Xu, Xiaosi Han, James M. Markert, Elizabeth A. Beierle, G. Yancey Gillespie	54
9	γ134.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia 2014 ·Gene Therapy ·Gregory K. Friedman, Li Nan, (unknown), V. Kelly, Blake P. Moore, Catherine P. Langford, Hongxia Xu, Xiaosi Han, Elizabeth A. Beierle, James M. Markert, Kevin A. Cassady, G. Yancey Gillespie	29
10	A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus 2013 ·Virology Journal ·Donghoon Chung, Blake P. Moore, Daljit S. Matharu, Jennifer E. Golden, Clinton Maddox, Lynn Rasmussen, Melinda Sosa, Subramaniam Ananthan, E. Lucile White, (unknown), Colleen B. Jonsson, William E. Severson	15
11	A Cell Based HTS Approach for the Discovery of New Inhibitors of RSV 2013 ·James W. Noah, William E. Severson, Donghoon Chung, Blake P. Moore, (unknown), (unknown), Clinton Maddox, Lynn Rasmussen, Melinda Sosa, (unknown), Subramaniam Ananthan, E. Lucile White, Colleen B. Jonsson, Daljit S. Matharu, Jennifer E. Golden, Thomas E. Prisinzano, Jeffrey Aubé	4
12	Identification of a Series of Quinazolinediones as Potent, Selective, Post-Entry Inhibitors of Human Respiratory Syncytial Virus ( h RSV) via a Cell-Based High Throughput Screen and Chemical Optimization 2013 ·James W. Noah, William E. Severson, Donghoon Chung, Blake P. Moore, (unknown), (unknown), Clinton Maddox, Lynn Rasmussen, Melinda Sosa, (unknown), Subramaniam Ananthan, (unknown), E. Lucile White, Colleen B. Jonsson, Daljit S. Matharu, Daniel P. Flaherty, Denise S. Simpson, Jennifer E. Golden, Jeffrey Aubé	4
13	(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a Small Molecule Inhibitor Probe for the Study of Respiratory Syncytial Virus Infection 2012 ·Journal of Medicinal Chemistry ·Blake P. Moore, (unknown), Daljit S. Matharu, Jennifer E. Golden, Clinton Maddox, Lynn Rasmussen, James W. Noah, Melinda Sosa, Subramaniam Ananthan, (unknown), E. Lucile White, (unknown), Thomas E. Prisinzano, Jeffrey Aubé, Colleen B. Jonsson, William E. Severson	15
14	A High-Throughput Screening Strategy to Overcome Virus Instability 2010 ·Assay and Drug Development Technologies ·Lynn Rasmussen, Clinton Maddox, Blake P. Moore, William E. Severson, E. Lucile White	13
15	A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus 2010 ·Europe PMC (PubMed Central) ·Donghoon Chung, Robert Ardecky, (unknown), Nicholas D. P. Cosford, Colleen B. Jonsson, Blake P. Moore, (unknown), Clinton Maddox, (unknown), E. Lucile White, Subramaniam Ananthan, Shuang Feng, Lynn Rasmussen, Ying Su, Thomas D.Y. Chung, (unknown), (unknown), Marintha Heil	1
16	HTS-Driven Discovery of New Chemotypes with West Nile Virus Inhibitory Activity 2010 ·Molecules ·(unknown), Colleen B. Jonsson, Clinton Maddox, (unknown), Blake P. Moore, Marintha Heil, E. Lucile White, Subramaniam Ananthan, Qianjun Li, Shuang Feng, Lynn Rasmussen	13
17	Alterations of BRMS1-ARID4A Interaction Modify Gene Expression but Still Suppress Metastasis in Human Breast Cancer Cells 2008 ·Journal of Biological Chemistry ·Douglas R. Hurst, Yi Xie, Kedar S. Vaidya, Alka Mehta, Blake P. Moore, Mary Ann Accavitti-Loper, Rajeev S. Samant, Ritu Saxena, Alexandra C. Silveira, Danny R. Welch	59
18	Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone 2006 ·Biochemical and Biophysical Research Communications ·Douglas R. Hurst, Alka Mehta, Blake P. Moore, Pushkar Phadke, William J. Meehan, Mary Ann Accavitti, Lalita A. Shevde, James E. Hopper, Yi Xie, Danny R. Welch, Rajeev S. Samant	60
19	Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1) 2005 ·Cancer Letters ·Rajeev S. Samant, Michael T. Debies, Douglas R. Hurst, Blake P. Moore, Lalita A. Shevde, Danny R. Welch	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact